Frederic H.  Moll net worth and biography

Frederic Moll Biography and Net Worth

Director of PROCEPT BioRobotics
Dr. Moll has served as a member of our board of directors since August 2011, and served as Chair from March 2021 to July 2024. From April 2019 to March 2023, Dr. Moll served as Chief Development Officer for Johnson & Johnson Medical Devices Companies. Dr. Moll was also a co-founder, and, from September 2012 to 2019, was the Chairman and Chief Executive Officer of Auris Health, Inc., a robotics medical device company, that was acquired by Johnson and Johnson in 2019. Dr. Moll is also the Founding Partner of Sonder Capital Management, LLC, a healthcare venture capital investment firm. He serves on the boards of Shockwave Medical, Inc., since March 2011, where he is a member of the nominating and corporate governance committee, and INSIGHTEC Ltd., since June 2020, where he is a member of the audit committee. Dr. Moll previously served as member and as Chairman of the board of Restoration Robotics, Inc., from November 2002 until its merger with Venus Concept in November 2019. Dr. Moll previously served on the board of directors at Intersect ENT, Inc. from March 2010 to February 2021, where he was a member of the nominating and corporate governance committee. Dr. Moll received a B.A. in economics from the University of California at Berkeley, an M.S. in management from Stanford University and an M.D. from the University of Washington.

What is Frederic H. Moll's net worth?

The estimated net worth of Frederic H. Moll is at least $27.74 million as of February 21st, 2024. Dr. Moll owns 287,521 shares of PROCEPT BioRobotics stock worth more than $27,740,026 as of December 3rd. This net worth evaluation does not reflect any other assets that Dr. Moll may own. Learn More about Frederic H. Moll's net worth.

How do I contact Frederic H. Moll?

The corporate mailing address for Dr. Moll and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at [email protected]. Learn More on Frederic H. Moll's contact information.

Has Frederic H. Moll been buying or selling shares of PROCEPT BioRobotics?

Frederic H. Moll has not been actively trading shares of PROCEPT BioRobotics during the last quarter. Most recently, Frederic H. Moll sold 79,000 shares of the business's stock in a transaction on Wednesday, December 6th. The shares were sold at an average price of $38.75, for a transaction totalling $3,061,250.00. Following the completion of the sale, the director now directly owns 808,233 shares of the company's stock, valued at $31,319,028.75. Learn More on Frederic H. Moll's trading history.

Who are PROCEPT BioRobotics' active insiders?

PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Alaleh Nouri (EVP), Hisham Shiblaq (EVP, Chief Commercial Officer), Kevin Waters (EVP, CFO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.

Are insiders buying or selling shares of PROCEPT BioRobotics?

In the last twelve months, insiders at the sold shares 34 times. They sold a total of 973,143 shares worth more than $70,081,453.91. The most recent insider tranaction occured on November, 27th when CEO Reza Zadno sold 26,420 shares worth more than $2,584,668.60. Insiders at PROCEPT BioRobotics own 17.4% of the company. Learn More about insider trades at PROCEPT BioRobotics.

Information on this page was last updated on 11/27/2024.

Frederic H. Moll Insider Trading History at PROCEPT BioRobotics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/6/2023Sell79,000$38.75$3,061,250.00808,233View SEC Filing Icon  
See Full Table

Frederic H. Moll Buying and Selling Activity at PROCEPT BioRobotics

This chart shows Frederic H Moll's buying and selling at PROCEPT BioRobotics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics logo
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $96.48
Low: $93.28
High: $97.41

50 Day Range

MA: $84.56
Low: $66.83
High: $99.27

2 Week Range

Now: $96.48
Low: $36.52
High: $103.81

Volume

485,633 shs

Average Volume

654,822 shs

Market Capitalization

$5.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99